Therefore, TGF-β role over the tumour cells is prominently suppressor in iCCA and, thus, the use of inhibitors targeting the TGF-β receptor may present counterproductive effects by inducing tumour cell proliferation. This evidence concerns the gene TGFB1 and neoplasm.